AZN | Complete AstraZeneca PLC stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
AstraZeneca Plc Share Company page Our story Webcasts Trade recap Fundamentals Analysis EquityWhat's this? Price (GBX)11,344.00 0.27% (30.00)AZNORD SHS $0.25 Track 6 more instruments Open / Last close11,422.00 / 11,344.00 High / Low11,438.00 / 11,314.00 ...
AstraZeneca PLC AZN:LSE Actions Health CarePharmaceuticals and Biotechnology Price (GBX)10,982.00 Today's Change-6.00 / -0.05% Shares traded3.04m 1 Year change+0.75% Beta0.3752 Data delayed at least 20 minutes, as of Jan 10 2025 14:42 GMT....
AstraZeneca PLC Stock Price History Beta (5Y Monthly) 0.194636 52-Week Change 24.14% S&P500 52-Week Change 20.43% 52 Week High 153.1 USD 52 Week Low 104.5 USD 50-Day Moving Average 147.43 USD 200-Day Moving Average 132.36 USD AZNCF Share Statistics Avg. Volume (3 month) 4.8K USD Avg...
AstraZeneca PLC (AZN) has a Smart Score of 10 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity.
AstraZeneca PLC Price AstraZeneca PLC price|AstraZeneca PLC Quote Zacks Rank & Key Picks AstraZeneca carries a Zacks Rank #3 (Hold). Some better-ranked stocks in the overall healthcare sector includeArcturus TherapeuticsARCT,BioventusBVSandFulcrum TherapeuticsFULC, each sporting a Zacks Rank #1 ...
1926:Imperial Chemical Industries (ICI, parent company of Zeneca PLC) founded in the UK. 1943:Astra develops Xylocane, which becomes the world's largest-selling local anesthetic. 1988:Hanakan Mogren appointed CEO of Astra AB. 1993:Zeneca PLC demerged from ICI. ...
AstraZeneca PLC Public LSE, NYSE and OMX: AZN Founded 6 April 1999 by merger Headquarters London, England, UK Key people David Brennan CEOTony Zook Vice President, North AmericaLouis Schweitzer ChairmanSimon Lowth CFOJohn Patterson CBE Executive Director, Development Industry Pharmaceutical Products ...
AstraZeneca PLC AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom. VALUATION P/E Current 35.29 P/E Ratio...
The Discovery Centre in Cambridge (UK) is one of our global science centres Explore all our science centres Sustainability at AstraZeneca Corporate Press Release Enhertu approved in the US as first HER2-directed therapy for patients with HER2-low or HER2-ultralow metastatic breast cancer following...